In This Article:
Cadrenal Therapeutics has entered a partnership with Abbott for the tecarfarin anticoagulation and haemocompatibility with left ventricular assist devices (TECH-LVAD) trial.
With Abbott’s support, Cadrenal aims to plan and execute the trial, which assesses the safety and efficacy of oral vitamin K antagonist, tecarfarin, in individuals with LVADs, under the partnership and data sharing agreement terms.
The company will receive Abbott’s insights from recent HeartMate 3 trials, including its support in designing the study, site recognition, trial awareness, and “expertise” on the HeartMate 3 LVAD.
Cadrenal Therapeutics CEO Quang Pham said: “We are pleased to have the support of Abbott, a global healthcare leader, which further validates the advancement into late-stage clinical development of tecarfarin. This partnership strengthens our access to key clinical trial sites and enhances patient enrolment efforts.
“Together, we have a unique opportunity to evaluate tecarfarin in combination with the HeartMate 3 LVAD, advancing our commitment to bringing forward the first innovation in vitamin K-targeted anticoagulation in over 70 years.”
Abbott’s mechanical circulatory support device, HeartMate 3 LVAD, is tailored for individuals with advanced heart failure. The device is used for both short- and long-term support in these patients.
It features Full MagLev Flow technology in the pump, which is said to “maintain” blood handling for decreasing complications as well as adverse events related to hemocompatibility.
Cadrenal is focused on developing tecarfarin to offer a “safer” anticoagulant alternative to warfarin for individuals with cardiac devices.
Tecarfarin has gained orphan drug designation for advanced heart failure individuals who are implanted with LVADs, and fast track status for those with end-stage kidney disease and atrial fibrillation.
"Cadrenal and Abbott sign agreement for LVAD trial of tecarfarin" was originally created and published by Medical Device Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.